Article
Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial.
The pharmacogenomics journal - 1 Dec 2015
Ellis K L, Zhou Y, Beshansky J R, Ainehsazan E, Selker H P, Cupples L A, Huggins G S, Peter I
Abstract excerpt
Modifiers of response to glucose, insulin and potassium (GIK) infusion may affect clinical outcomes in acute coronary syndromes (ACS). In an Immediate Myocardial Metabolic Enhancement During Initial Assessment And Treatment In Emergency Care (IMMEDIATE) trial's sub-study (n = 318), we explored effects of 132,634 genetic variants on plasma glucose and potassium response to 12-h GIK infusion. Associations between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
